Abstract
A 24-year-old, right-handed woman presented with a three-day history of worsening left monocular visual loss. She initially noted an ‘oily smudge’ over her central visual field while using her computer at work. Bright colors were less vibrant. Symptoms progressed over the next 2 days to visual loss involving most of the left monocular visual field. For the past day, she noted left retro-orbital pain, particularly at the extremes of eye movement. When she covered the left eye, vision with the right eye was normal. There were no other neurological symptoms and no history of previous transient neurological symptoms. Her past medical history was unremarkable and she took no regular medications. There was no family history of neurologic or autoimmune disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69292-692302.
Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med. 1998;339:285-291.
D’hooghe MB, Haentjens P, Nagels G, D’Hooghe T, De Keyser J. Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis. J Neurol. 2012;259:855-861.
Hellwig K, Chen L, Langer-Gould A. Hormonal contraceptives and multiple sclerosis susceptibility (S34.003). Neurology. 2014;82:S34.003.
Pastò L, Portaccio E, Ghezzi A, et al. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol. 2012;12:165.
Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet. 1988;29:533-541.
Lu E, Wang BW, Guimond C, Synnes A, Sadovnick D, Tremlett H. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology. 2012;79:1130-1135.
Houtchens MK, Kolb C. M. Multiple sclerosis and pregnancy: therapeutic considerations. J Neurol. 2013;260:1202-1214.
Cree BA. Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis. Mult Scler. 2013;19:835-843.
Food and Drug Administration (FDA). Content and format of labeling for human prescription drug and biological products. Requirements for pregnancy and lactation labeling. Federal Register. 2008;73:30831-30868.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lincoln, M.R., Oh, J. (2017). Prenatal planning in multiple sclerosis. In: Giacomini, P. (eds) Case Studies in Multiple Sclerosis. Adis, Cham. https://doi.org/10.1007/978-3-319-31190-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-31190-6_16
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-31188-3
Online ISBN: 978-3-319-31190-6
eBook Packages: MedicineMedicine (R0)